San Antonio, TX (September 20, 2002) – A new analysis of scientific data presented at today's meeting of the American Society for Bone and Mineral Research (ASBMR) showed that a 5 mg dose of Actonel® ...

Cincinnati, Ohio; Bridgewater, N.J. (February 10, 2003) –Newly published data show that treatment with 5 mg Actonel® (risedronate sodium tablets) daily reduced the risk of spinal fracture in ...

CINNCINNATI, Ohio, Aug. 14 (UPI) -- The U.S. Food and Drug Administration late last week approved Procter & Gamble's osteoporosis drug Actonel for a new use in men. The agency approved Actonel ...

NEW YORK (Reuters Health) - The results of a new study suggest that Actonel (risedronate) provides greater fracture protection in the first year of therapy than does Fosamax (alendronate). Among ...

CINCINNATI (AdAge.com) -- Procter & Gamble Co. has shifted global advertising duties for osteoporosis drug Actonel to a team of Omnicom Group agencies, including DDB Worldwide, New York, DDB's ...

US consumer goods behemoth Procter & Gamble announced yesterday [Thursday] that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company’s risedronate sodium tablets, for the ...

Risedronate (Actonel) is a bisphosphonate which also includes the drugs alendronate prescribed for the treatment of Paget's disease of bone (a disease in which the formation of bone is abnormal) and ...

LONDON--(BUSINESS WIRE)--FOR MEDICAL BUSINESS/INDUSTRY TRADE MEDIA ONLY A real world evidence study, presented at the 13 th International Conference on Osteoporosis, Arthritis and Musculoskeletal ...

Q. I saw an ad for a "whole body vibration training" program at the gym. Does standing on a vibrating platform actually do anything for your body? A. Ah, this brings back memories of the 1950s and ...

Actonel has been around since 2000 and has sales in excess of $1 billion, while Boniva debuted in 2003 and has grown slowly, with sales of $13 million for GSK and $28 million for Roche in the first ...

Aug. 18, 2005 -- The U.S. Food and Drug Administration (FDA) has approved calcitonin-salmon [rDNA origin] nasal spray for the treatment of osteoporosis in women more than five years after menopause; a ...